Aspira Women's Health Inc. (AWH)
| Market Cap | 11.73M |
| Revenue (ttm) | 8.96M |
| Net Income (ttm) | -14.80M |
| Shares Out | 16.06M |
| EPS (ttm) | -1.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 51,230 |
| Open | 0.730 |
| Previous Close | 0.713 |
| Day's Range | 0.670 - 0.748 |
| 52-Week Range | 0.670 - 5.650 |
| Beta | 1.44 |
| Analysts | Buy |
| Price Target | 4.40 (+502.74%) |
| Earnings Date | Nov 14, 2024 |
About AWH
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company’s products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1’s high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeter... [Read more]
Financial Performance
In 2023, Aspira Women's Health's revenue was $9.15 million, an increase of 11.85% compared to the previous year's $8.18 million. Losses were -$16.69 million, -44.15% less than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for AWH stock is "Buy." The 12-month stock price forecast is $4.4, which is an increase of 502.74% from the latest price.
News
Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call Transcript
Aspira Women's Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Nicole Sandford - Chief Executive Officer & Director Sandy Milligan - Presid...
Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024
Management to Announce Earnings Results and hold a call at 8:30 am ET Management to Announce Earnings Results and hold a call at 8:30 am ET
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024
Event to feature presentations from Dr. Kevin Elias, Dr. Richard Gersh, Dr. Sandra Milligan, and Dr. Todd Pappas on the Company's development pipeline Event to feature presentations from Dr. Kevin Eli...
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health
Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis
Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®
New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation (CLEP) approval allows for OvaWatch® to be marketed in New York State New York State Department of Health (NYSDOH) Clinical ...
AWH Stock Plummets as Financial Data Reflects Losses
Annex Insurance (AWH, Financial) stock recently experienced a sharp decline, dropping 7.47% to $0.761 per share. The trading volume stood at 16,266 shares, with a turnover rate of 0.10% and a price fl...
Aspira Womens Health (AWH) Shares Plunge Amid Financial Challenges
Aspira Womens Health (AWH, Financial) experienced a significant stock price drop of 7.80%, reaching $0.775 per share. The trading volume stood at 14,064 shares with a turnover rate of 0.09% and a vola...
Aspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
AUSTIN, Texas, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease d...
Aspira Women's Health Inc. (AWH) Q2 2024 Earnings Call Transcript
Aspira Women's Health Inc. (NASDAQ:AWH) Q2 2024 Earnings Conference Call August 12, 2024 4:30 PM ET Company Participants Nicole Sandford - CEO and Director Sandy Milligan - President Conference Call ...
Aspira Women's Health Reports Second Quarter 2024 Financial Results
Q2 2024 OvaSuite S M revenue of $2.4 million and volume of 6,471 units
Aspira Women's Health's Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women's Health (NPWH) Women's Healthcare Conference
AUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease di...
Aspira Women's Health Announces Closing of $1.9 Million Private Placement Equity Financing
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynec...
Aspira Women's Health Announces $1.935 Million Private Placement Equity Financing
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynec...
Aspira Women's Health Provides Commercial, Reimbursement and Cash Guidance Updates
Monthly OvaSuiteSM product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expanded Anthem and Medicaid coverage for OvaSuite Cash used in operations gui...
Aspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyneco...
Aspira Women's Health Inc. (AWH) Q1 2024 Earnings Call Transcript
Aspira Women's Health Inc. (NASDAQ:AWH) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Nicole Sandford - CEO Sandy Milligan - President Torsten Hombeck - CFO Conference ...
Aspira Women's Health Reports First Quarter 2024 Financial Results
Q1 2024 OvaSuite S M revenue of $2.2 million and volume of 5,829 units
UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyneco...
Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyneco...
Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, and Medicaid Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, a...
Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript
Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript
Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth quarter an...
Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference
AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyne...
Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024
AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyne...
Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynec...